#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma stage IV Vernal keratoconjunctivitis Cystic fibrosis respiratory infection suppression Chronic myeloid leukaemia (in remission) Loeys-Dietz syndrome Measles Partial lipodystrophy White matter lesion Dermatitis Hyperadrenocorticism Glomerulonephritis membranoproliferative Vaginal cancer Aplastic anaemia Angiosarcoma recurrent Candida infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Treatment Mantle cell lymphoma stage III – Diagnostics Thrombotic thrombocytopenic purpura Fragile X syndrome – Life with Disease Angiosarcoma non-metastatic – Life with Disease Loeys-Dietz syndrome – Treatment Gaucher’s disease type III – Trials in Disease Mantle cell lymphoma stage III – Life with Disease Methylmalonic acidaemia – Diagnostics Osteosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Molgramostim Befiradol (18F) Risankizumab Azd4831 Diclofenac Diethylamine Specific Nucleic Acid Sna-Veru Bromhexine Hydrochloride Meclofenamate Sodium Folic Acid Itraconazole Specific Nucleic Acid Sna-Her2 Hydrocortisone Acetate Sirexatamab Aceclofenac Ziltivekimab GSK5764227 Xp-Dc+Tl+Klh Blinatumomab Sulpiride Blu-222 More therapies…

    Learn about Your Condition

    Heparin resistance Anogenital dysplasia Hypertonic bladder Mesothelioma Niemann-Pick disease Rheumatic disorder Thalassaemia beta Nephrogenic anaemia Corticobasal degeneration Medullary thyroid cancer Metastases to rectum Delayed graft function Stomatitis Appendicitis perforated Acarodermatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Pentoxifylline, Retinol Acetate, and DL-Alpha Tocopherol Acetate for Patients with Medication-Related Osteonecrosis of the Jaw

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteonecrosis of jaw
    Investigated Drugs:
    • Dl-Alpha Tocopherol Acetate
    • Pentoxifylline
    • Retinol Acetate
    France

  • Study on Early Rituximab Treatment for Children with Nephrotic Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Rituximab
    Poland

  • Study on the Effects of Wharton’s Jelly Mesenchymal Stem Cells, Pirfenidone, and Nintedanib for Patients with Fibrotic Interstitial Lung Disease

    Recruiting

    1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Allogeneic Wharton’s Jelly-Derived Mesenchymal Stem Cells
    • Nintedanib
    • Pirfenidone
    Poland

  • Study on Clebopride for Treating Rumination Syndrome in Patients Suspected of Having the Condition

    Recruiting

    3 1 1
    Investigated Diseases:
    • Merycism
    Investigated Drugs:
    • Clebopride Hydrogen Maleate
    Belgium

  • Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

    Recruiting

    2 1
    Investigated Drugs:
    • Namodenoson
    Bulgaria Poland Romania

  • Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    Belgium Croatia France Germany Greece Ireland +6
Previous Page
1 … 634 635 636 637 638 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!